SK Bioscience Begins Supplying Novavax’s Updated COVID-19 Vaccine for XBB Subvariant
SEOUL, Dec. 12 (Korea Bizwire) — SK bioscience Co. said Tuesday it has started supplying Novavax’s updated COVID-19 vaccine to target the XBB.1.5 subvariant in South Korea. The vaccine, the only non-messenger RNA formulation against COVID-19 in the world, will be available for free at designated hospitals and health centers across the country starting next [...]